Boston, MA 03/07/2014 (wallstreetpr) –Biostar Pharmaceuticals Inc (NASDAQ:BSPM) has stated that its long time dream has always been to come up with a new treatment and cure for liver cancer. That is why the company is excited about its just announced collaboration with Shaanxi University of Chinese Medicine.
So then, what next? The company has many plans including more studis to develop drugs for other cancer diseases and conditions. Yet the company is now putting its best foot forward to invest large amount of resources and capital in supporting its promising project in the treatment of liver cancer. To this end, it will be working with Shaanxi University of Chinese Medicine’s Research Institute of Pharmaceuticals.
The company and the institute hope that their collaboration will lead to speedy development of new medicine for cancer that is based on Oleanolic Acid. Primarily Biostar Pharmaceuticals Inc (NASDAQ:BSPM) is in the business of developing, manufacturing and marketing of drugs and health supplements that are targeted at various health conditions and diseases.
The headache posed by cancer
Cancer is a killer disease around the world and there have been very few medical breakthroughs in controlling and treating the disease or conditions related to it. Pharmaceutical companies all around the world are dedicating resources and talents to research and develop cancer treatment. As the threat of cancer grows all around the world, proving solution for the disease is seen as a big business.
According to the data provided by World Health Organization (WHO), new cancer cases and deaths have gone up sharply in recent years – and these have been reported all around the world. For example, in 2012, at least 14 million new cancer cases were recorded and about 8.2 million deaths related to cancer occurred in the year.
In these grim statistics, China where Biostar Pharmaceuticals Inc (NASDAQ:BSPM) is headquartered had the highest cancer cases and fatality figures in the mentioned year. In fact, the figures issued by Chinese authorities as relating to cancer infections and deaths are higher than those supply by WHO.
Investor Takeaway
Biostar Pharmaceuticals Inc (NASDAQ:BSPM) has been undertaking study on Oleanic acid. And so far its scientists are almost satisfied that the technology they are developing has remarkable success in killing cancer cells and Hepatitis B virus (HBV).
